Cardiovascular diseases (CVD) are responsible for a substantial portion of global health issues, with rising numbers of cases in both developed and developing nations. The challenges associated with CVD are multifaceted, involving a complex interplay of genetic, environmental, and socioeconomic factors. In many regions, limited access to quality healthcare and the increasing prevalence of risk factors like obesity, diabetes, and smoking contribute to the growing burden of heart disease. Tackling these global cardiovascular challenges demands innovative public health strategies that emphasize prevention, equitable access to care, and the education of populations about the importance of lifestyle modifications. Efforts at a global level to address these issues will play a key role in reducing the impact of CVD on health systems worldwide.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : Finite-Element and Electromagnetic Cardio-Vascular Simulation for Drug Testing, Monitoring, and Safety Projection Using Bansal B–Bio Framework
Abhishek Bansal, New Era Consultancy Services, India
Title : Lipid and High-Density Lipoprotein (HDL) Subfraction Changes in Premenopausal and Postmenopausal Women with Breast Cancer Receiving Hormonal Therapy
Sofra Maria, Aretaieion University Hospital, Greece